IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,408,000 | +48.3% | 251,371 | +70.9% | 0.01% | +50.0% |
| Q2 2022 | $1,624,000 | +242.6% | 147,121 | +416.9% | 0.00% | +300.0% |
| Q1 2022 | $474,000 | -90.2% | 28,460 | -88.8% | 0.00% | -88.9% |
| Q4 2021 | $4,839,000 | +1.2% | 253,480 | +30.8% | 0.01% | -10.0% |
| Q3 2021 | $4,780,000 | +397.9% | 193,814 | +425.2% | 0.01% | +400.0% |
| Q2 2021 | $960,000 | -17.9% | 36,905 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $1,169,000 | -34.4% | 36,905 | -3.8% | 0.00% | -25.0% |
| Q4 2020 | $1,781,000 | +38.8% | 38,365 | -1.6% | 0.00% | +33.3% |
| Q3 2020 | $1,283,000 | +70.4% | 38,975 | +42.1% | 0.00% | +50.0% |
| Q2 2020 | $753,000 | -8.3% | 27,419 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $821,000 | +47.1% | 27,419 | +36.2% | 0.00% | +200.0% |
| Q4 2019 | $558,000 | – | 20,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |